Onward Medical N.V. (EBR: ONWD)

Market Cap	165.87M
Revenue (ttm)	532.00K
Net Income (ttm)	-36.18M
Shares Out	34.63M
EPS (ttm)	-1.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,782
Open	4.800
Previous Close	4.790
Day's Range	4.750 - 4.800
52-Week Range	1.850 - 6.580
Beta	0.84
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 27, 2024

About Onward Medical

Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer inter...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 99
• Stock Exchange: Euronext Brussels
• Ticker Symbol: ONWD

Financial Performance

In 2023, AGFB's revenue was 1.15 billion, an increase of 0.44% compared to the previous year's 1.15 billion. Losses were -102.00 million, -53.85% less than in 2022.